Thurston Springer Miller Herd & Titak’s CVS Health CVS Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$282K	Sell	2,725 -39	-1%	-$3.48K	0.1%	208
2026 Q1	$199K	Sell	2,764 -264	-9%	-$20.3K	0.08%	254
2025 Q4	$240K	Buy	3,028 +2,765	+1,051%	+$218K	0.08%	230
2025 Q3	$19.8K	Sell	263 -11,790	-98%	-$808K	0.04%	286
2025 Q2	$832K	Buy	12,053 +1,195	+11%	+$78.4K	0.11%	192
2025 Q1	$736K	Buy	10,858 +1,757	+19%	+$105K	0.12%	157
2024 Q4	$409K	Buy	9,101 +1,296	+17%	+$72.7K	0.08%	198
2024 Q3	$491K	Buy	7,805 +1,914	+32%	+$112K	0.14%	164
2024 Q2	$348K	Buy	+5,891	New	+$369K	0.11%	178

Other funds holding CVS

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's CVS Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak reduced its CVS Health (CVS) stake by 1.4% in Q2 2026, selling an estimated $3.48K and leaving 2,725 shares worth $282K. The position accounts for 0.1% of the portfolio, ranked #208.

Thurston Springer Miller Herd & Titak first reported a position in CVS in Q2 2024 and has held it in 9 quarters since. The position peaked at $832K in Q2 2025. 783 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Thurston Springer Miller Herd & Titak held 2,725 shares of CVS Health worth $282K as of Q2 2026.
Thurston Springer Miller Herd & Titak sold 39 CVS Health shares in Q2 2026, an estimated $3.48K.
CVS Health made up 0.1% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #208 holding.
Thurston Springer Miller Herd & Titak first reported a position in CVS Health in Q2 2024 and has held it in 9 quarters since.
Thurston Springer Miller Herd & Titak's CVS Health position peaked at $832K in Q2 2025.
783 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.